Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment.
Nogova L, Mattonet C, Scheffler M, Taubert M, Gardizi M, Sos ML, Michels S, Fischer RN, Limburg M, Abdulla DSY, Persigehl T, Kobe C, Merkelbach-Bruse S, Franklin J, Backes H, Schnell R, Behringer D, Kaminsky B, Eichstaedt M, Stelzer C, Kinzig M, Sörgel F, Tian Y, Junge L, Suleiman AA, Frechen S, Rokitta D, Ouyang D, Fuhr U, Buettner R, Wolf J. Nogova L, et al. Among authors: fuhr u. Cancer Med. 2020 Jul;9(14):4991-5007. doi: 10.1002/cam4.3131. Epub 2020 May 21. Cancer Med. 2020. PMID: 32436621 Free PMC article. Clinical Trial.
Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.
Kinzig-Schippers M, Fuhr U, Cesana M, Müller C, Staib AH, Rietbrock S, Sörgel F. Kinzig-Schippers M, et al. Among authors: fuhr u. Antimicrob Agents Chemother. 1998 Sep;42(9):2359-64. doi: 10.1128/AAC.42.9.2359. Antimicrob Agents Chemother. 1998. PMID: 9736563 Free PMC article. Clinical Trial.
Mesalazine pharmacokinetics and NAT2 phenotype.
Lück H, Kinzig M, Jetter A, Fuhr U, Sörgel F. Lück H, et al. Among authors: fuhr u. Eur J Clin Pharmacol. 2009 Jan;65(1):47-54. doi: 10.1007/s00228-008-0550-2. Epub 2008 Aug 14. Eur J Clin Pharmacol. 2009. PMID: 18704388 Free article. Clinical Trial.
In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O, Fuhr U, Kunz D, Frank D, Kinzig M, Jetter A, Reith Y, Lazar A, Taubert D, Kirchheiner J, Baum M, Eisenbrand G, Berger FI, Bertow D, Berkessel A, Sörgel F, Schömig E, Tomalik-Scharte D. Doroshyenko O, et al. Among authors: fuhr u. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):433-43. doi: 10.1158/1055-9965.EPI-08-0832. Epub 2009 Feb 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19190172 Free article.
Development of a new G-CSF product based on biosimilarity assessment.
Gascon P, Fuhr U, Sörgel F, Kinzig-Schippers M, Makhson A, Balser S, Einmahl S, Muenzberg M. Gascon P, et al. Among authors: fuhr u. Ann Oncol. 2010 Jul;21(7):1419-1429. doi: 10.1093/annonc/mdp574. Epub 2009 Dec 17. Ann Oncol. 2010. PMID: 20019087 Free article. Clinical Trial.
219 results